Cipla Smashes Records with 47% Profit Surge: Is Their Pivot to Biology the Real Story?

Cipla just reported a stellar FY2024, crossing the ₹25,000 crore revenue mark with a massive 47% …

Sep 9, 2025 19:26

Unichem Labs' Roha Facility Receives Positive USFDA VAI Classification

Unichem Laboratories’ Roha API facility received a ‘Voluntary Action Initiated’ …

Sep 1, 2025 00:24

Cipla's Bommasandra Plant Gets Favorable USFDA Nod! 💊

Cipla’s Bengaluru manufacturing facility received a ‘Voluntary Action Indicated’ …

Aug 5, 2025 09:06

Senores Pharma's Havix Unit: USFDA Inspection Concludes, Stock at ₹644 📉

Senores Pharmaceuticals’ US subsidiary, Havix, completed its USFDA inspection with 3 minor …

Jul 28, 2025 15:54

Shilpa Medicare's Bengaluru Unit Gets Positive USFDA Nod, Stock Up 4.8%! 📈

Shilpa Medicare’s Bengaluru Unit VI received a positive USFDA inspection outcome (VAI), …

Jul 16, 2025 11:32